Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer’s disease and mild cognitive impairment

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with clinical, biological, and pathological features occurring along a continuum from normal to end-stage disease. Currently, the diagnosis of AD depends on clinical assessments and post-mortem neuropathology, which is unbenefited...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Weilin, Lin, Huawei, He, Xiaojun, Chen, Lewen, Dai, Yaling, Jia, Weiwei, Xue, Xiehua, Tao, Jing, Chen, Lidian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190828/
https://www.ncbi.nlm.nih.gov/pubmed/32350238
http://dx.doi.org/10.1038/s41398-020-0801-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190828/
https://www.ncbi.nlm.nih.gov/pubmed/32350238
http://dx.doi.org/10.1038/s41398-020-0801-2

Ejemplares similares